Drugs with Coverage Limitations and New Drug Review
Please Note:
- Date Review Completed and Conclusion columns are blank for those products currently undergoing review. Details will be updated as efficiently as possible following initial review.
- Conclusions are based upon decisions made at the time reviews are completed; historical information is not updated. Product management is subject to change based on new clinical evidence, provider/public feedback, advisory committee recommendations, financial considerations, etc.
- This contains approximately one year of New Drug details.
- Advisory Meeting Month is the month this recommendation will be presented at the quarterly Drug Prior Authorization Committee (DPAC) and Drug Utilization Review (DUR) Board meetings. For meeting dates, please see the MO HealthNet Calendar of Events. Certain agents may also be discussed at the quarterly Rare Disease Advisory Council meeting immediately prior to their presentation at their designated DPAC/DUR meeting.
For more information on this process please view the New Drug Review Process or contact the MO HealthNet Pharmacy Program at MHD.PharmacyAdmin@dss.mo.gov or call 573-751-6963.
| Trade Name | Generic Name | Date Review Began | Date Review Completed | Conclusion | Advisory Committee Month |
|---|---|---|---|---|---|
| ELFABRIO 20 MG/10 ML VIAL | PEGUNIGALSIDASE ALFA-IWXJ | 05/23/2023 | 07/05/2023 | Clinical Edit | October 2023 |
| TAFINLAR 10 MG TABLET FOR SUSP | DABRAFENIB MESYLATE | 05/23/2023 | 07/05/2023 | PDL Product | October 2023 |
| AMJEVITA(CF) 10MG/0.2ML SYRING | ADALIMUMAB-ATTO | 05/23/2023 | 07/05/2023 | PDL Product | October 2023 |
| MEKINIST 0.05 MG/ML SOLUTION | TRAMETINIB DIMETHYL SULFOXIDE | 05/23/2023 | 07/05/2023 | PDL Product | October 2023 |
| LIQREV 10 MG/ML ORAL SUSP | SILDENAFIL CITRATE | 05/23/2023 | 07/05/2023 | PDL Product | October 2023 |
| UZEDY ER 50 MG/0.14 ML SYRINGE | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |
| SOGROYA 5 MG/1.5 ML PEN | SOMAPACITAN-BECO | 05/16/2023 | 06/27/2023 | PDL Product | July 2023 |
| UZEDY ER 75 MG/0.21 ML SYRINGE | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |
| UZEDY ER 250 MG/0.7 ML SYRINGE | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |
| UDENYCA 6 MG/0.6 ML AUTOINJECT | PEGFILGRASTIM-CBQV | 05/16/2023 | 06/27/2023 | PDL Product | October 2023 |
| UZEDY ER 200 MG/0.56 ML SYRING | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |
| KALYDECO 13.4 MG GRANULES PKT | IVACAFTOR | 05/16/2023 | 06/27/2023 | Clinical Edit | October 2023 |
| UZEDY ER 150 MG/0.42 ML SYRING | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |
| ZOLPIDEM TARTRATE 7.5 MG CAP | ZOLPIDEM TARTRATE | 05/16/2023 | 06/27/2023 | PDL Product | October 2023 |
| UZEDY ER 125 MG/0.35 ML SYRING | RISPERIDONE | 05/16/2023 | 06/27/2023 | Resource List | October 2023 |